Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chiari

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oncogene|August 15, 1996
The aminoterminal phosphotyrosine binding domain of Shc associates with ZAP-70 and mediates TCR dependent gene activationE Milia, M M Di Somma, F Baldoni, et al.
Theriogenology|November 18, 2005
Factors potentially affecting fertility of lactating dairy cow recipientsJ L M Vasconcelos, D G B Demétrio, R M Santos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 24, 2019
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancerB Ricciuti, M Brambilla, A Cortellini, et al.
Cancer Research|April 28, 2001
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survivalV Karanikas, D Colau, J F Baurain, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutationsV Ludovini, F Bianconi, L Pistola, et al.
ESMO Open|April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?N Silvestris, M Di Maio, A Russo, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluationGiulio Metro, R Chiari, M Mare, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2013
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patientsV Ludovini, A Flacco, F Bianconi, et al.
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|August 15, 1996
The aminoterminal phosphotyrosine binding domain of Shc associates with ZAP-70 and mediates TCR dependent gene activationE Milia, M M Di Somma, F Baldoni, et al.
Theriogenology|November 18, 2005
Factors potentially affecting fertility of lactating dairy cow recipientsJ L M Vasconcelos, D G B Demétrio, R M Santos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 24, 2019
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancerB Ricciuti, M Brambilla, A Cortellini, et al.
Cancer Research|April 28, 2001
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survivalV Karanikas, D Colau, J F Baurain, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2012
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutationsV Ludovini, F Bianconi, L Pistola, et al.
ESMO Open|April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?N Silvestris, M Di Maio, A Russo, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluationGiulio Metro, R Chiari, M Mare, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2013
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patientsV Ludovini, A Flacco, F Bianconi, et al.
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
Pageof 6